| BCBS Federal Medical & Drug | 2.04.148 Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes (ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, and TP53) | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.152 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes | 2025-06-01 |
| BCBS Federal Medical & Drug | 4.01.19 Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis | 2025-06-01 |
| BCBS Federal Medical & Drug | 6.01.25 Minimally Invasive Approaches to Vertebral Fractures and Osteolytic Lesions of the Spine | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.05 Cochlear Implant | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.13 Surgical Treatment of Bilateral Gynecomastia | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.15 Meniscal Allografts and Other Meniscal Implants | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.21 Reduction Mammaplasty for Breast-Related Symptoms | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.47 Bariatric Surgery | 2025-06-01 |
| BCBS Federal Medical & Drug | 7.01.48 Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions | 2025-06-01 |